BACKGROUND: Lichen planopilaris is a frequent presentation of primary cicatricial alopecia. Scalp distribution characterizes the main clinical presentations: classic lichen planopilaris, frontal fibrosing alopecia and Graham-Little Piccardi-Lassueur Syndrome (GLPLS). OBJECTIVE: Description of the clinical, dermoscopic and histopathological findings of Lichen planopilaris in public and private practices. METHOD: A retrospective observational study was performed by reviewing medical records of patients with lichen planopilaris. RESULTS: Eighty patients were included, 73 (91,25%) were female. Prototype II was seen in 53 (66,25%) patients. Classic lichen planopilaris was seen in 62,5% of the cases. Frontal fibrosing alopecia was seen in 31% of the patients and only one patient presented Graham-Little Piccardi-Lassueur Syndrome (GLPLS). Scalp lesions were scattered throughout the scalp in 47 (58,75%) of the patients, while 24 (30%) presented mainly central scalp lesions, 29 (36,25%) presented marginal lesions and only 4 (5%) patents had vertex lesions. CONCLUSIONS: Clinical presentation of Lichen planopilaris varies. To recognize the heterogeneity of the clinical appearance in lichen planopilaris is important for differential diagnosis.
BACKGROUND: Lichen planopilaris is a frequent presentation of primary cicatricial alopecia. Scalp distribution characterizes the main clinical presentations: classic lichen planopilaris, frontal fibrosing alopecia and Graham-Little Piccardi-Lassueur Syndrome (GLPLS). OBJECTIVE: Description of the clinical, dermoscopic and histopathological findings of Lichen planopilaris in public and private practices. METHOD: A retrospective observational study was performed by reviewing medical records of patients with lichen planopilaris. RESULTS: Eighty patients were included, 73 (91,25%) were female. Prototype II was seen in 53 (66,25%) patients. Classic lichen planopilaris was seen in 62,5% of the cases. Frontal fibrosing alopecia was seen in 31% of the patients and only one patient presented Graham-Little Piccardi-Lassueur Syndrome (GLPLS). Scalp lesions were scattered throughout the scalp in 47 (58,75%) of the patients, while 24 (30%) presented mainly central scalp lesions, 29 (36,25%) presented marginal lesions and only 4 (5%) patents had vertex lesions. CONCLUSIONS: Clinical presentation of Lichen planopilaris varies. To recognize the heterogeneity of the clinical appearance in lichen planopilaris is important for differential diagnosis.
Lichen planopilaris is a common form of primary cicatricial alopecia. Lymphocytic
inflammatory process occurs at isthmus level destroying the follicle germ cells.
Distribution of the lesions on the scalp characterize the main clinical forms.[1] Its variable clinical features postpone
the diagnosis hindering the dermatologist daily practice.Three clinical variants of the lichen planopilaris can be classically observed: the
classic form (LPP), the frontal fibrosing alopecia (FFA) and the
Graham-Little-Piccardi-Lassueur syndrome (GLPLS).[2] The classic form manifests with alopecia plaques preferably at the
vertex, but the scalp may be affected anywhere (Figure
1).[1] FFA, described by
Kossard in 1994, is characterized by progressive cicatricial alopecia affecting the hair
implant in the frontotemporal region (Figure 2).
It was initially described only in postmenopausal women, but several cases have been
reported in premenopausal women and even in men.[3] The third form, GLPLS, is characterized by the triad: cicatricial
alopecia of the scalp, non-cicatricial alopecia in the armpit and pubis, and lichenoid
papules on the trunk and extremities.[4]
In some cases, FFA may have some characteristics of GLPLS, showing that these forms may
overlap.[5]
Figure 1
Patient presenting classic form of lichen planopilaris with alopecia plaques at
the vertex
Figure 2
Patient with advanced frontal fibrosing alopecia characterized by progressive
cicatricial alopecia affecting the implant hairline in the frontotemporal
region
Patient presenting classic form of lichen planopilaris with alopecia plaques at
the vertexPatient with advanced frontal fibrosing alopecia characterized by progressive
cicatricial alopecia affecting the implant hairline in the frontotemporal
region
Objectives
Description of clinical, dermoscopic and histopathologic findings of lichen planopilaris
and its variants in the city of Curitiba, in the State of Paraná (South region of
Brazil) in two healthcare centers, one public and one private.
METHODS
An observational and retrospective study was performed through review of medical records
of patients diagnosed with lichen planopilaris. The study was approved by the Ethics
Committee of the Universidade Federal do Paraná (UFPR) and registered in Brazil research
platform.The study included patients assisted at the scalp disordersoutpatient clinic of the
Hospital das Clínicas de Curitiba - UFPR between 2010 and 2013 and at the private clinic
CEPELLE - Centro Especializado da Pele between 2008 and 2013. In addition to clinical
diagnosis, patients should present histological and/or dermoscopic criteria compatible
with LPP. Histological findings of lymphocytic cicatricial alopecia with perifollicular
infiltrate at the isthmus were essential for inclusion in the study. This finding should
be linked to at least one of the following: presence of Civatte bodies, perifollicular
lichenoid infiltrate or a suggestive dermoscopic finding of cicatricial alopecia by
LPP.[6] Patients who had
associated periannexal infiltrate, basement membrane thickening or dermal mucinosis, in
addition to cases with other findings suggesting systemic lupus erythematosus or discoid
lupus, were excluded. Dermoscopic criteria for exclusion were: presence of atrophic
white spots, periplaque perifollicular hyperkeratosis, isolated terminals stalk or, more
rarely, hyperpigmentation of perifollicular halo.The study excluded patients without histological confirmation of lymphocytic cicatricial
alopecia. A total of 80 patients was included in the study. Among these, 16 were from
the scalp disordersoutpatient clinic at Hospital de Clínicas - UFPR. The remaining 64
patients were treated at the private clinic CEPELLE - Centro Especializado da Pele.A standard questionnaire was formulated. Among the questions assessed were demographics
(age, gender and skin type) and also data related to the disease, such as disease
duration, clinical form, distribution of lesions on the scalp, involvement of other
hairy areas, simultaneous diagnoses on the scalp, other sites of lichen planus, local
symptoms, findings on clinical and dermoscopic examination, histopathologic findings,
previous and current treatments and serology for hepatitis. Questions were answered by
the researchers using data obtained from medical records. In some cases it was not
possible to fill the questionnaire due to lack of data in retrospective notes.The descriptive analysis of the data was made by building contingency tables for
categorical variables. For continuous variables, some descriptive measures were
calculated: mean, standard deviation, minimum and maximum.To compare patient groups, the chi-square test was applied when the conditions for using
the test were met.
RESULTS
Of the 80 patients, 73 (91.25%) were women and 7 (8.75%) were men. Regarding the
phototype, 53 (66.25%) were phototype II, 24 (30%) were phototype III and 3 (3.75%) were
phototype IV. The two groups of patients (public and private practice) showed similar
profiles. There was no significant difference between the groups regarding age.Classic form of LPP was found in 50 (62.5%) patients whereas fibrosing alopecia in a
pattern distribution (FAPD) was evident in 9 (11.25%) patients and FFA in 29 (31%)
patients. Only one patient presented GLPLS.Concerning the distribution of alopecia plaques on the scalp, 47 (58.75%) patients had
random plaques, 24 (30%) had central distribution, 29 (36.25%) presented frontal
marginal involvement, and 4 (5%) patients showed vertex involvement.Involvement of axillary hair was observed in 16 (20%) patients. Decrease in genital hair
occurred in 8 (10%) patients as well as involvement of hair of upper limbs. Loss of hair
in the lower limbs was seen in 9 (11.25%) patients. Involvement of eyelashes was noted
in 3 (3.75%) patients.Seven patients presented involvement of other areas by LP. Oral lesions occurred in 2
patients, one with FFA and the other with FAPD. Two patients with LPP had pterygium
nail. A patient with FFA had involvement of the 20 nails. LP skin lesions have been
reported in one patient with LPP form of the disease and in one patient with FAPD,
synchronously with scalp expression.All included patients underwent at least a scalp biopsy; 29 patients underwent more than
one biopsy at different times. Sixty-three (78.75%) patients had lymphocytic cicatricial
alopecia with involvement, in line or sparse, of the radicular sheath, on follicular
isthmus level. The remaining 17 cases showed scattered lymphocytes and perifollicular
fibrosis, "onion skin-like", with follicular consumption. Of these 17 cases, 11
presented the classical clinical form of LPP and 6 presented FFA, but also showing
clinical and dermoscopic findings suggestive of LPP. Among the dermoscopic findings,
perifollicular hyperkeratosis was observed in 15 patients, white spots in 12 patients,
isolated strands in 6 patients and perifollicular hyper-pigmentation in 2 patients.
Patients were subdivided into 3 groups according to clinical aspect. Classic LPP was
considered when confluent random plaques were observed. FFA was considered in patients
with alopecia in the line of hair implant of frontotemporal region. And GLPLS was
considered in cases of cicatricial alopecia of scalp associated with non-cicatricial
alopecia in armpit and/or pubis and lichenoid papules on the trunk and/or limbs.In the classic LPP group it was possible to characterize 2 distinct clinical features.
One group with confluent random plaques distributed throughout the scalp and other with
confluent plaques in the central region of the scalp, clinically similar to male pattern
or female pattern androgenetic alopecia, what is called fibrosing alopecia in a pattern
distribution (FAPD). This variant has increasingly been described as a variation of LPP;
although clinically similar to male pattern or female pattern androgenetic alopecia, the
perifollicular linchenoid inflammatory process histologically characterizes this entity
(Figure 3).[7] Both in FFA as in FAPD the trigger for lichenoid process seems to
be associated with the miniaturization of the follicles.[1]
Figure 3
Patient with fibrosing alopecia in a pattern distribution showing confluent
alopecia plaques in the central region of the scalp
Patient with fibrosing alopecia in a pattern distribution showing confluent
alopecia plaques in the central region of the scalpRegarding the dermoscopic findings, 54 of the 80 cases presented description of
dermoscopic examination in the medical records. The dermoscopic findings are shown in
table 1.
Table 1
Dermatoscopic findings
DERMATOSCOPIC FINDING
Number of patients with positive finding
% of the patients with positive finding
REDUCTION OF NUMBER OF FOLLICLES
48
88.88%
PERIFOLLICULAR HYPERKERATOSIS
47
87.03%
POLYTRICHA
20
37.03%
WHITE DOTS
21
38.88%
VISIBLE VESSELS
30
55.55%
BLACK DOTS
03
5.55%
PIGMENTED HALO
05
9.255
ISOLATED TERMINAL STALK
19
35.18%
Dermatoscopic findingsAmong the treatments employed, 65 patients used antimalarials, 53 used topical minoxidil
and 30 patients used intralesional corticosteroids. The use of topical corticosteroids
was observed in 52 patients, of systemic corticosteroids in 19 patients, of antibiotics
in 9 patients and of mycophenolate mofetil in 3 patients.Phototype II was the most frequently affected: 64% of patients with LPP, 72% of patients
with FFA.
DISCUSSION
Lichen planopilaris, also called follicular lichen or follicular lichen planus, was
initially described by Pringle in 1895.[1] It is a form of lichen planus with primary involvement of the hair
follicle. As in lichen planus, its etiology is not well understood and most often
affects white women.[2] Around 17-28% of
cases may be associated with lichen planus lesions in hairless skin, mucous membranes
and nails.[2] In the described sample,
the first major Brazilian group of LPP, association was found with other forms of LP in
8.75% of cases. Among them, 2.5% affecting the skin and the same percentage affecting
the mucosa. Nail involvement occurred in 8.75% of cases. One case of FFA presented
associated LP pigmentosum.Differential diagnosis of cicatricial alopecia is a clinical challenge to the
dermatologist. LPP can mask alopecia areata (AA) in its classical form and the ophiasic
form of AA can be masked by FFA. FAPD and FFA might be mistaken for androgenetic
alopecia. Diagnosis of LPP is suspected in the presence of cicatricial alopecia plaques,
single or multiple, presenting perifollicular hyperkeratosis, erythema, mainly on the
periphery of scarring lesion. Itching, stinging and burning may also be
present.[1] In such cases,
histological evaluation is essential.Scalp trichoscopy/dermoscopy allows analysis of the epidermal portion of the hair
follicle and also the epidermis of the perifollicular scalp.[8]Among the most frequently observed dermoscopic findings, perifollicular hyperkeratosis
and reduction of the number of follicles was observed in 95.92% and 96% of the cases
examined, respectively. These data are similar to those previously described in the
literature.[1,8,9] In the described
sample, black dots were observed on dermoscopic examination of 3 patients. Black dots
are classically described in patients with AA and trichotillomania but had not yet been
observed in patients with LP. These patients had no other associated diagnoses that
could justify these findings. As with AA, these dots may be due to disease activity or
external manipulation of the stalks in processes to camouflage the flaws, which may
break strands and form black dots, similar to what occurs in trichotillomania. LPP is a
diagnostic challenge. Clinical, dermoscopic and histopathologic findings may provide
data for a definitive diagnosis. Dermoscopy of LPP is not characteristic, but associated
with clinical and histological findings of cicatricial alopecia, to define the
diagnosis. Clinical spectrum of LPP is varied. Classic form of LPP was responsible for
more than half (62.5%, n=50) of cases. In this group, 18% (n=9) of patients presented
FAPD, accounting for 11.25% of the total patients. In the current sample, an
uncharacteristic group was evident, but already discussed in cicatricial alopecia
consensus. It was possible to distinguish FAPD from the other 3 groups by the central
and diffuse involvement of the scalp (Figure 1).
LPP cases have been described after hair transplant surgery and thus considered as a
Koebner phenomenon, but they might actually be misdiagnosed FAPD, treated as
androgenetic alopecia.[10]White areas described classically in LPP are irregular white spots that can come
together forming white-cicatricial areas.[8] These structures correspond histopathologically to fibrous bands and
can also be seen in other types of folliculocentric cicatricial alopecias.[8] Perifollicular scales or perifollicular
hyperkeratosis are highly suggestive of LPP, presenting white-gray color with tubular
aspect emerging around the strand axis, which is better visualized by dry dermatoscopy
without immersion.[8] They
histologically correspond to perifollicular hyperkeratosis and vacuolar changes with
presence of necrotic keratinocytes in the basal layer of the hair follicle and outer
root sheath.[8]Isolated strands are seen in cicatricial alopecia and correspond to the previous sites
of inflammation with loss of follicles on the site.[8] In FFA they can be evidenced in frontal and marginal implant
hairline in the scalp.[8]Perifollicular halo or target hyperpigmentation are seen as perifollicular blue-gray
dots that correspond histologically to pigment leakage that occurs in LPP interface
dermatites.[9]Presence of elongated blood vessels arranged parallel to each other can be found in the
periphery of LPP active plaques.[8]
There is no histopathological correlation known to date for these findings.[8] However, as in most cases, only
dermatoscopy with 10x magnification was performed and often this finding was not
valued.FFA, considered a LPP rare variant, was observed in 29 (31%) patients. Since the
description of the first 6 cases in Brazil in 2007, several cases have been evaluated,
suggesting that this entity is actually underdiagnosed and not rare.[11] Only 1 patient presented criteria for
GLPLS, which matches the rarity described in the literature.Treatment of LPP is controversial and often disappointing. As a cicatricial alopecia,
the main goal of therapy is to prevent the progression of the lesions. Early diagnosis
and intervention can change the course of the disease. Among the treatment options
available, the evaluated group used topical, intralesional and systemic corticosteroids;
hydroxychloroquine; acitretin; and mycophenolate mofetil. Other options, such as
cyclosporine, thalidomide and griseofulvin, have been used with variable response, but
were not used by the patients included in this sample.[1,2,3]
CONCLUSION
Clinical presentation of LPP is diverse. Recognition of forms of LPP initial
presentation is critical to the dermatologist, since this is a cicatricial alopecia that
requires early intervention. Early forms may present mild hair loss so other
differential diagnoses must be considered. Dermatoscopy and scalp biopsy complement the
evaluation of LPP.The study presents as limitation the fact that data were collected through medical
records review, which may present some incomplete or distorted information.
Authors: Bruna Duque-Estrada; Bruna Duque Estrada; Carla Tamler; Celso Tavares Sodré; Carlos Baptista Barcaui; Francisco Burnier Carlos Pereira Journal: An Bras Dermatol Date: 2010 Mar-Apr Impact factor: 1.896
Authors: Heliana Freitas de Oliveira Góes; Maria Fernanda Reis Gavazzoni Dias; Simone de Abreu Neves Salles; Caren Dos Santos Lima; Müller da Silva Vieira; Luciana Pantaleão Journal: An Bras Dermatol Date: 2017 Jul-Aug Impact factor: 1.896
Authors: Damia L Vendramini; Bruno R L Silveira; Bruna Duque-Estrada; Ana Letícia Boff; Celso Tavares Sodré; Rodrigo Pirmez Journal: Skin Appendage Disord Date: 2016-09-14
Authors: David Saceda-Corralo; Pablo Fernández-Crehuet; Pablo Fonda-Pascual; Cristina Pindado-Ortega; Oscar M Moreno-Arrones; Sergio Vañó-Galván Journal: Skin Appendage Disord Date: 2017-09-09
Authors: Daniela Pinto; Francesco Maria Calabrese; Maria De Angelis; Giuseppe Celano; Giammaria Giuliani; Fabio Rinaldi Journal: PLoS One Date: 2022-07-18 Impact factor: 3.752
Authors: Sergio Vañó-Galván; David Saceda-Corralo; Ulrike Blume-Peytavi; Jose Cucchía; Ncoza C Dlova; Maria Fernanda Reis Gavazzoni Dias; Ramon Grimalt; Daniela Guzmán-Sánchez; Matthew Harries; Anthony Ho; Susan Holmes; Jorge Larrondo; Anisa Mosam; Rui Oliveira-Soares; Giselle M Pinto; Bianca M Piraccini; Rodrigo Pirmez; Daniel De la Rosa Carrillo; Lidia Rudnicka; Jerry Shapiro; Rodney Sinclair; Antonella Tosti; Ralph M Trüeb; Annika Vogt; Mariya Miteva Journal: Skin Appendage Disord Date: 2019-04-02
Authors: Uwe Wollina; Birgit Heinig; André Koch; Andreas Nowak; Georgi Tchernev; Katlein França; Torello Lotti Journal: Open Access Maced J Med Sci Date: 2018-01-10